Breast cancer-related deaths according to grade in ductal carcinoma in situ: A Dutch population-based study on patients diagnosed between 1999 and 2012
- PMID: 30059817
- DOI: 10.1016/j.ejca.2018.07.003
Breast cancer-related deaths according to grade in ductal carcinoma in situ: A Dutch population-based study on patients diagnosed between 1999 and 2012
Abstract
Background: The incidence of ductal carcinoma in situ (DCIS) has drastically increased over the past decades. Because DCIS is resected after diagnosis similar to invasive breast cancer, the natural cause and behaviour of DCIS is not well known. We aimed to determine breast cancer-specific survival (BCSS) and overall survival (OS) according to grade in DCIS patients after surgical treatment in the Netherlands.
Patients and methods: All DCIS patients diagnosed between 1999 and 2012 were selected from the Netherlands Cancer Registry. The cause of death was obtained from 'Statistics Netherlands'. BCSS and OS were estimated using multivariable Cox regression in the entire cohort and stratified for grades.
Results: In total, 12,256 patients were included, of whom 1509 (12.3%) presented with grade I, 3675 (30.0%) with grade II, 6064 (49.5%) with grade III and 1008 (8.2%) with an unknown grade. During a median follow-up of 7.8 years, 1138 (9.3%) deaths were observed, and 179 (1.5%) were breast cancer-related. Of these, 10 patients had grade I; 46 grade II; 95 grade III and 28 an unknown grade. After adjustment for confounding, grade II and III were related to worse BCSS than grade I with hazard ratios of 1.92 (95% confidence interval [CI]: 0.97-3.81) and 2.14 (95% CI: 1.11-4.12), respectively. No association between grades and OS was observed.
Conclusion: BCSS and OS in DCIS patients were excellent. Because superior rates were observed for low-grade DCIS, it seems justified to investigate whether active surveillance may be a balanced alternative for conventional surgical treatment.
Keywords: Breast cancer-specific survival; Breast cancer–related deaths; Ductal carcinoma in situ; Population-based study.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
Significant inter- and intra-laboratory variation in grading of ductal carcinoma in situ of the breast: a nationwide study of 4901 patients in the Netherlands.Breast Cancer Res Treat. 2019 Apr;174(2):479-488. doi: 10.1007/s10549-018-05082-y. Epub 2018 Dec 11. Breast Cancer Res Treat. 2019. PMID: 30539380 Free PMC article.
-
Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor.Clin Breast Cancer. 2013 Oct;13(5):385-91. doi: 10.1016/j.clbc.2013.04.005. Epub 2013 Jul 17. Clin Breast Cancer. 2013. PMID: 23870857
-
The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.Breast Cancer Res. 2017 Mar 9;19(1):26. doi: 10.1186/s13058-017-0819-4. Breast Cancer Res. 2017. PMID: 28274272 Free PMC article.
-
Clinical Outcomes of Conservative Treatment for Low-Risk Ductal Carcinoma in Situ: A Systematic Review and Pooled Analysis.Clin Oncol (R Coll Radiol). 2023 Apr;35(4):255-261. doi: 10.1016/j.clon.2023.01.019. Epub 2023 Feb 1. Clin Oncol (R Coll Radiol). 2023. PMID: 36764879
-
Prognostic significance of microinvasion with ductal carcinoma in situ of the breast: a meta-analysis.Breast Cancer Res Treat. 2023 Jan;197(2):245-254. doi: 10.1007/s10549-022-06800-3. Epub 2022 Nov 24. Breast Cancer Res Treat. 2023. PMID: 36427119 Free PMC article. Review.
Cited by
-
Adherence to guideline recommendations for follow-up in patients with DCIS at a large teaching hospital in the Netherlands.Breast Cancer Res Treat. 2024 Oct;207(3):633-640. doi: 10.1007/s10549-024-07391-x. Epub 2024 Jun 14. Breast Cancer Res Treat. 2024. PMID: 38874687
-
Patterns of treatment and outcome of ductal carcinoma in situ in the Netherlands.Breast Cancer Res Treat. 2021 May;187(1):245-254. doi: 10.1007/s10549-020-06055-w. Epub 2021 Jan 1. Breast Cancer Res Treat. 2021. PMID: 33385265 Free PMC article.
-
Risk perception of patients with ductal carcinoma in situ (DCIS) of the breast and their healthcare practitioners: The importance of histopathological terminology, and the gaps in our knowledge.Histol Histopathol. 2025 Mar;40(3):297-306. doi: 10.14670/HH-18-806. Epub 2024 Sep 3. Histol Histopathol. 2025. PMID: 39324807 Review.
-
Comparison of the ductal carcinoma in situ between White Americans and Chinese Americans.Medicine (Baltimore). 2021 Jan 22;100(3):e24136. doi: 10.1097/MD.0000000000024136. Medicine (Baltimore). 2021. PMID: 33546026 Free PMC article.
-
Critical appraisal of the 2 mm threshold in ductal carcinoma in situ: methodological concerns in meta-analysis of margin width and local recurrence risk.Gland Surg. 2025 Apr 30;14(4):771-775. doi: 10.21037/gs-2025-108. Epub 2025 Apr 25. Gland Surg. 2025. PMID: 40405944 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous